Atezolizumab Plus nab-Paclitaxel in the Treatment of Metastatic Triple-Negative Breast Cancer With 2-Year Survival Follow-up: A Phase 1b Clinical Trial
暂无分享,去创建一个
S. Adams | L. Molinero | J. Diamond | P. Pohlmann | S. Tolaney | J. Powderly | R. Funke | K. Iizuka | E. Hamilton | Wei Zhang | Ching-Wei Chang | P. Foster